Literature DB >> 30119232

Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway.

Lijun Yang1, Kaiyan Sun2, Jie Chu3, Yunhui Qu4, Xue Zhao5, Huiqing Yin6, Liang Ming7, Junhu Wan8, Fucheng He9.   

Abstract

AIMS:: Recent research showed that Long non-protein coding RNA ferritin heavy chain 1 pseudogene 3 (FTH1P3) plays a crucial role in the course of tumor formation. The present study was aimed to explore its role in esophageal squamous cell carcinoma (ESCC). MAIN
METHODS: Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was used to examine the expression levels of FTH1P3, mRNA SP1 and NF-kB in ESCC samples and cell lines. The impact of FTH1P3 knockdown was evaluated by WST-1 assays, colony formation assays, scratch wound assays, migration and invasion assays. KEY
FINDINGS: FTH1P3 was significantly upregulated in ESCC tissues and cells (P < 0.001). Knockdown of FTH1P3 notably decreased the proliferation, migration, and invasion capacity of ESCC cells. Silencing of FTH1P3 decreased the expression of specificity protein 1 (Sp1) and NF-kB (p65) in EC9706 and EC1. SIGNIFICANCE: FTH1P3 plays a crucial role in ESCC tumorigenesis, and can be used as a potential therapeutic target for ESCC.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biological function; Esophageal squamous cell carcinoma; FTH1P3; Long non-coding RNA

Mesh:

Substances:

Year:  2018        PMID: 30119232     DOI: 10.1016/j.biopha.2018.07.129

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma.

Authors:  Wei Mao; Jian Ding; Yu Li; Ruofei Huang; Baoxin Wang
Journal:  Exp Ther Med       Date:  2022-06-16       Impact factor: 2.751

2.  Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway.

Authors:  Lijun Yang; Yafei Ye; Jie Chu; Jinlin Jia; Yunhui Qu; Ting Sun; Huiqing Yin; Liang Ming; Junhu Wan; Fucheng He
Journal:  Cancer Manag Res       Date:  2019-05-13       Impact factor: 3.989

3.  Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression.

Authors:  Jia Gao; Ziteng Zhang; Hong Su; Ling Zong; Yan Li
Journal:  Cancer Manag Res       Date:  2020-03-26       Impact factor: 3.989

Review 4.  Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy.

Authors:  Xiaomin Liu; Yang Shao; Jinbao Zhou; Guangren Qian; Zhongliang Ma
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-18       Impact factor: 8.886

5.  LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis.

Authors:  Jinlin Jia; Hongle Li; Jie Chu; Jinxiu Sheng; Chang Wang; Zimo Jia; Weiwei Meng; Huiqing Yin; Junhu Wan; Fucheng He
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

Review 6.  FTH1 Pseudogenes in Cancer and Cell Metabolism.

Authors:  Maddalena Di Sanzo; Barbara Quaresima; Flavia Biamonte; Camillo Palmieri; Maria Concetta Faniello
Journal:  Cells       Date:  2020-11-28       Impact factor: 6.600

Review 7.  The roles of long noncoding RNAs in breast cancer metastasis.

Authors:  Lingxia Liu; Yu Zhang; Jun Lu
Journal:  Cell Death Dis       Date:  2020-09-14       Impact factor: 8.469

Review 8.  Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.

Authors:  Qingqing Feng; Hongli Zhang; Denglin Yao; Wei-Dong Chen; Yan-Dong Wang
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

Review 9.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

10.  LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis.

Authors:  Jianwei Tang; Honglei Xu; Qiang Liu; Jianan Zheng; Cheng Pan; Zhihua Li; Wei Wen; Jun Wang; Quan Zhu; Zhibo Wang; Liang Chen
Journal:  Aging (Albany NY)       Date:  2021-05-18       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.